BOSTON SCIENTIFIC CORP — Director's Dealing 2015

Feb 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-02-16

Reporting Person: Dawkins Keith D (EVP, Global Chief Med. Off.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-16	Common Stock	M	3375.0000	$0.0000	Acquired	146563.0000	Direct
2015-02-16	Common Stock	F	1097.0000	$14.9800	Disposed	145466.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-16	Deferred Stock Units	$	M	3375.0000	Disposed		Common Stock (3375.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.

F3: Reflects multiple DSU awards with independent vesting schedules.